Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Agrynex
AddedFeb 17, 2024
UpdatedJun 18, 2026
Agrynex

Agrynex

Angel

Agrynex: Providing biocidal enzymes for crop protection against soil-borne diseases.

HQ
Ithaca, NY, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize agricultural pesticides, Agrynex focuses on delivering biodegradable, sustainable biocidal enzymes to protect crops against soil-borne diseases. The company's vision emphasizes efficacy, safety, and sustainability, aiming to enhance food system production through nature-inspired solutions. Agrynex's core products are biocidal enzymes designed to offer an eco-friendly alternative to traditional chemical pesticides, targeting the agricultural market.

Agrynex has garnered attention for its innovative approach to crop protection, attracting notable investors and industry experts committed to sustainable agriculture. Key achievements include successful field trials demonstrating the effectiveness of their biocidal enzymes and partnerships with leading agricultural institutions. The overall impact of Agrynex lies in its potential to reduce the environmental footprint of farming while maintaining high crop yields, contributing significantly to the future of sustainable agriculture.

Agrynex - Similar Companies

AgBiome logo

AgBiome

agbiome.com

AgriMetis logo

AgriMetis

Enko logo

Enko

enko.ag

Agradis logo

Agradis

Agrivida logo

Agrivida

agrivida.com

Agragene logo

Agragene

agragene.com

Boragen logo

Boragen

EcoPesticides logo

EcoPesticides

Crop Enhancement logo

Crop Enhancement

Innatrix logo

Innatrix

innatrix.com

Lytos Technologies logo

Lytos Technologies

lytostech.com

Ascribe Bioscience logo

Ascribe Bioscience

ascribebio.com

Emerald Bioagriculture logo

Emerald Bioagriculture

emeraldbio.com

Organicin Scientific logo

Organicin Scientific

AgroSpheres logo

AgroSpheres

agrospheres.com

Agrynex - Quick Facts

Who are Agrynex's competitors?

Companies similar to Agrynex include AgBiome, AgriMetis, Enko and Agradis.

When was Agrynex founded?

Agrynex was founded in 2015.

Where is Agrynex's headquarters located?

Agrynex's headquarters is located in Ithaca, NY, US.

When was Agrynex's last funding round?

Agrynex's most recent funding round was for $50k (USD) in April 2023.

How much has Agrynex raised to-date?

As of Apr 13, 2023, Agrynex has raised a total of $50k (USD).

How many employees does Agrynex have?

Agrynex has 4 employees as of Feb 4, 2024.

Agrynex - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopesticides
  • Crop Protection
Tags
  • AgTech
NAICS
  • 320000Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 4 more industry codes
NAICS
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified